Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM

Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM

IntroductionThe personalized management of differentiated thyroid cancer (DTC) is currently based on the postoperative TNM staging system and the ATA risk stratification system (RSS), both updated in 2018 and 2015, respectively.PurposeWe aimed to evaluate the impact of the last two editions of TNM a...

Full description

Bibliographic Details
Main Authors:	Giulia Sapuppo, Sonia Grasso, Guenda Di Benedetto, Antonino Belfiore, Gabriella Pellegriti
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Endocrinology
Subjects:	differentiated thyroid cancer thyroid cancer outcome thyroid cancer risk factors persistent or recurrent disease TNM staging system risk stratification system TNM staging and ATA risk stratification systems
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1128963/full

Similar Items

The Initial ATA Risk Classification, but Not the AJCC/TNM Stage, Predicts the Persistence or Relapse of Differentiated Thyroid Cancer in Long-Term Surveillance
by: Stefania Giuliano, et al.
Published: (2022-08-01)

The New TNM Staging System for Thyroid Cancer and the Risk of Disease Downstaging
by: Claudio Casella, et al.
Published: (2018-09-01)

Blood preoperative neutrophil-to-lymphocyte ratio is correlated with TNM stage in patients with papillary thyroid cancer
by: Wenjie Gong, et al.

A novel nomogram and risk stratification system predicting the cancer-specific survival of patients with gastric neuroendocrine carcinoma: a study based on SEER database and external validation
by: Xue Song, et al.
Published: (2023-07-01)

Impact of the updated TNM staging criteria on prediction of persistent disease in a differentiated thyroid carcinoma cohort
by: Carla Fernanda Nava, et al.

Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan
by: Jui-Hung Sun, et al.
Published: (2022-12-01)

Patients Aged ≥55 Years With Stage T1-2N1M1 Differentiated Thyroid Cancer Should Be Downstaged in the Eighth Edition AJCC/TNM Cancer Staging System
by: Zeming Liu, et al.
Published: (2019-10-01)

A Practical Nomogram and Risk Stratification System Predicting the Cancer-Specific Survival for Patients With Advanced Hepatocellular Carcinoma
by: Dashuai Yang, et al.
Published: (2022-07-01)

Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine
by: Danuta Ga˛sior-Perczak, et al.
Published: (2017-09-01)

Staging of lung cancer in a tertiary care setting in Sri Lanka, using TNM 7<sup>th </sup>edition. A comparison against TNM6
by: Dassanayake Dinesh LB, et al.
Published: (2012-03-01)

P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
by: Liu Q, et al.
Published: (2018-07-01)

Dynamic prediction of the risk of recurrence in patients over 60 years of age with differentiated thyroid carcinoma
by: Yanina Jimena Morosán, et al.
Published: (2016-02-01)

Significance of ypTNM stage in determining the prognosis and therapy after surgery for locally advanced rectal cancer
by: Yue Chen, et al.
Published: (2023-06-01)

A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database
by: Xiangxing Kong, et al.
Published: (2018-01-01)

Small Cell Lung Cancer and TNM Staging
by: Ke-Neng CHEN
Published: (2016-06-01)

Does size affect the prognosis of resectable thymoma beyond the eighth edition TNM?
by: Yen‐Chiang Tseng, et al.
Published: (2022-02-01)

Controversies in the TNM staging system for colorectal cancer
by: Samornmas Kanngurn
Published: (2010-08-01)

The number of metastatic lymph nodes optimizes staging in patients aged 55 years or older with papillary thyroid cancer
by: Yun-Gang Sun, et al.
Published: (2022-12-01)

TNM stage in the Nordic Cancer Registries 2004–2016: Registration and availability
by: Gerda Engholm, et al.
Published: (2024-05-01)

How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?
by: Noha Mukhtar, et al.
Published: (2023-10-01)

A multipurpose TNM stage ontology for cancer registries
by: Nicholas Charles Nicholson, et al.
Published: (2022-02-01)

Comparative Analysis of AI-SONICTM Thyroid System and Six Thyroid Risk Stratification Guidelines in Papillary Thyroid Cancer: A Retrospective Cohort Study
by: Wang M, et al.
Published: (2024-08-01)

Principles of medullary thyroid cancer staging according to AJCC TNM 8th edition
by: O.R Duda, et al.
Published: (2021-05-01)

The proposed modification of TNM staging and therapeutic strategy for skip metastasis in papillary thyroid carcinoma: A multicenter retrospective cohort study
by: Zheyu Yang, et al.
Published: (2023-06-01)

Establishment of an Ultrasound Malignancy Risk Stratification Model for Thyroid Nodules Larger Than 4 cm
by: Xuehua Xi, et al.
Published: (2021-06-01)

A simplified T classification based on the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma
by: Pan XX, et al.
Published: (2019-04-01)

Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients
by: Jae-Ghi Lee, et al.
Published: (2025-01-01)

Editorial: Papillary thyroid cancer: prognostic factors and risk assessment
by: Vincenzo Marotta, et al.
Published: (2025-03-01)

Lymph node ratio versus TNM system as prognostic factor in colorectal cancer staging. A single Center experience
by: Moccia Francesco, et al.
Published: (2019-07-01)

Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival
by: Michael Ried, et al.
Published: (2017-12-01)

Revision of the TNM Stage Grouping in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
by: Bo YE, et al.
Published: (2016-06-01)

Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer
by: Andrew G Gianoukakis, et al.
Published: (2024-02-01)

Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer
by: Jiwoong Jung, et al.
Published: (2018-11-01)

Shear Wave Elastography and Thyroid Imaging Reporting and Data System (TIRADS) for the Risk Stratification of Thyroid Nodules—Results of a Prospective Study
by: Manuela Petersen, et al.
Published: (2022-01-01)

Rethinking the 8th AJCC System: Is It Suitable for Patients Aged <55 Years With Stage T4N1M0 Follicular Variant of Papillary Thyroid Carcinoma to Be Placed in Stage I?
by: Wei Long, et al.
Published: (2020-12-01)

Sensitivity to thyroid hormone indices are associated with papillary thyroid carcinoma in Chinese patients with thyroid nodules
by: Jie Sun, et al.
Published: (2023-06-01)

Correlations between vascular endothelial growth factor expression, microvascular density in tumor tissues and TNM staging in breast cancer
by: Comşa Şerban, et al.
Published: (2012-01-01)

Risk factor analysis for inaccurate pre-operative MRI staging in rectal cancer
by: Zerong Cai, et al.
Published: (2020-03-01)

Stratification of papillary thyroid cancer relapse risk based on the results of molecular genetic studies
by: S. A. Lukyanov, et al.
Published: (2020-04-01)

Enhancing clinical decision-making: A novel nomogram for stratifying cancer-specific survival in middle-aged individuals with follicular thyroid carcinoma utilizing SEER data
by: Chenghao Zhanghuang, et al.
Published: (2024-06-01)